These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38779854)

  • 21. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
    Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD
    Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
    Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
    Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
    Pojskic L; Pojskic B
    Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
    Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S
    J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-Wide Association Study Identifies a Functional
    León-Mimila P; Villamil-Ramírez H; Macías-Kauffer LR; Jacobo-Albavera L; López-Contreras BE; Posadas-Sánchez R; Posadas-Romero C; Romero-Hidalgo S; Morán-Ramos S; Domínguez-Pérez M; Olivares-Arevalo M; López-Montoya P; Nieto-Guerra R; Acuña-Alonzo V; Macín-Pérez G; Barquera-Lozano R; Del-Río-Navarro BE; González-González I; Campos-Pérez F; Gómez-Pérez F; Valdés VJ; Sampieri A; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Aguilar-Salinas CA; Vargas-Alarcón G; Shih D; Meikle PJ; Calkin AC; Drew BG; Vaca L; Lusis AJ; Huertas-Vazquez A; Villarreal-Molina T; Canizales-Quinteros S
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2494-2508. PubMed ID: 34233476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
    Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.
    Nikkola E; Ko A; Alvarez M; Cantor RM; Garske K; Kim E; Gee S; Rodriguez A; Muxel R; Matikainen N; Söderlund S; Motazacker MM; Borén J; Lamina C; Kronenberg F; Schneider WJ; Palotie A; Laakso M; Taskinen MR; Pajukanta P
    Atherosclerosis; 2017 Sep; 264():58-66. PubMed ID: 28772107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.
    Ellis KL; Pang J; Chieng D; Bell DA; Burnett JR; Schultz CJ; Hillis GS; Watts GF
    Clin Cardiol; 2018 Mar; 41(3):378-384. PubMed ID: 29480541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Miname MH; Santos RD
    Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia.
    Bertolini S; Pisciotta L; Di Scala L; Langheim S; Bellocchio A; Masturzo P; Cantafora A; Martini S; Averna M; Pes G; Stefanutti C; Calandra S
    Atherosclerosis; 2004 May; 174(1):57-65. PubMed ID: 15135251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
    Berry ASF; Jones LK; Sijbrands EJ; Gidding SS; Oetjens MT
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2058-2067. PubMed ID: 37589137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.